Literature DB >> 19590171

Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.

Robert Feldmann1, Michael Schierl, Matthias Sittenthaler, Reinhild Jahn, Christian Wogritsch, Lorenzo Cerroni, Andreas Steiner, Friedrich Breier.   

Abstract

Intravascular large B-cell lymphoma (IVBCL) is a rare malignant neoplasm characterized by the proliferation of large B cells within the blood vessels. The disease can be limited to the skin, but involvement of other organs is common. We report a case of cutaneous IVBCL in a 62-year-old man with minimal histological changes in contrast to prominent skin lesions. The patient was successfully treated with rituximab in combination with CHOP chemotherapy. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590171     DOI: 10.1159/000228328

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

Review 1.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

2.  Asian-variant intravascular lymphoma in the African race.

Authors:  Holly Geyer; Nina Karlin; Brian Palen; Ruben Mesa
Journal:  Rare Tumors       Date:  2012-03-19

Review 3.  Novel applications of Rituximab in dermatological disorders.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian Dermatol Online J       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.